Roche sees diagnostic sales soar after acquisition:
This article was originally published in Clinica
Executive Summary
Roche's diagnostic division had sales of SwFr4.6 billion ($3.3 billion) in 1998, reflecting the Swiss company's acquisition of Boehringer Mannheim in mid-1997. In the previous year, Roche's diagnostic sales were SwFr966 million. Roche says its PCR-based products and patient care division both had double-digit sales growth, its molecular biochemicals division had substantial growth, while its laboratory systems sales were "down sightly in a saturated market". Roche's total sales were SwFr24,660 million, up 31%. The figures do not include turnover for the orthopaedics company DePuy, in which Roche had a majority holding and which was sold to Johnson & Johnson in July 1998.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.